Principles and Practice of Pharmaceutical Medicine

between 1972 and 1994’.Br. J. Clin. Pharmacol.45:
151–156.
Munk W. 1878.The Roll of Royal College of Physicians
of London, Vol. II (1701–1800). Royal College of
Physicians: Pall Mall East, London; 159–164.
Rubin S. 1975.Medieval English Medicine. David &
Charles: Newton Abbot; 43–128.
Stenton FM. 1947. ‘Anglo Saxon England’. InOxford
History of England, 2nd edn. Oxford University
Press: Oxford; 266.
Speirs CJ, Griffin JP. 1983. ‘A survey of the first year of
operation of the new procedure affecting the conduct
of clinical trials in the United Kingdom’.Br. J. Clin.
Pharmacol.15: 649–655.
Speirs CJ, Saunders RM, Griffin JP. 1984. ‘The United
Kingdom Clinical Trial Exemption Scheme – its
effects on investment in research’.Pharm. Int.5:
254–256.

Watson G. 1966.Theriac and Mithridatium. A Study in

Therapeutics. The Wellcome Historical Library:

London.

Recommended information

sources

The European Agency for the Evaluation of Medicinal

Products. 1995, 1996, 1997.First, Second and Third

General Reports. EMEA: 7 West Ferry Circus, Canary

Wharf, London E14 4HB, UK.

EC.The Rules Governing Medicinal Products in the

European Community, Vols I–IV. Commission of the

European Communities: Brussels.

Medicines Control Agency. 1994/5, 1995/6, 1996/7.

Annual Report and Accounts. HMSO: London.

RECOMMENDED INFORMATION SOURCES 441